Policy and Medicine Archive for March, 2022

Click a link below to view the mailing archive as if it had been sent to you.

2022-03-31 12:30		FDA Issues New Set of Guidances Focused on Generic Drug Submissions and Labeling Updates
2022-03-30 12:30		FDA-Duke to Host Public Workshop Focused on Key Competencies for Opioid Prescriber Education
2022-03-29 12:30		OPDP Issued Six Letters in 2021
2022-03-28 12:30		Califf Narrowly Voted by Senate to Be Next FDA Commissioner
2022-03-26 12:30		CME-MOC Webinar Series to Update Clinicians on Latest in NASH (non-alcoholic steatohepatitis) Diagnosis and Management
2022-03-25 12:30		Michigan Makes Changes to Laws Surrounding Pharmacy Benefit Managers
2022-03-24 12:30		Teva Reaches $225 Million Settlement with Texas Over Opioid Claims
2022-03-23 12:30		Pharmacists’ Role to Expand Over the Next Decade
2022-03-22 12:30		MedPAC Presents MA Findings, Including Increased Spending
2022-03-21 12:30		Ten Individual Indicted in $300 Million Healthcare Fraud
2022-03-18 12:30		Diagnostic Company Reaches False Claims Act Settlement
2022-03-17 12:30		OPDP Sends “Bad Ad” Warning Letter over PARAGARD Video
2022-03-16 12:30		California Court Rules that FMV Payments Can Qualify as Illegal Kickbacks
2022-03-15 12:30		Mallinckrodt Reaches $260 Million Anti-Kickback Settlement
2022-03-14 12:30		Connecticut Governor Proposes Price Restrictions on Prescription Drugs
2022-03-13 12:30		CME Webinar Series Guides Clinicians on Individualizing HER2-Positive Breast Cancer Treatment
2022-03-12 12:30		Policy and Medicine Compliance Update March 2022 Issue Features: Global Regulatory Changes, Oregon Rep Licensure, FDA vs 1st Amendment, and DOJ Yates 2.0
2022-03-11 12:30		OPDP Sends Warning Letter to CytoDyn Over Promotional Video for Its IND Leronlimab
2022-03-10 12:30		District of Delaware Rules HRSA Exceeded Its Authority in Issuing 340B Enforcement Letters
2022-03-09 12:30		CMS Announces New Flexibilities to QPP and MIPS
2022-03-08 12:30		Tribal Nations Reach Multi-Million-Dollar Settlement Over Opioid Claims
2022-03-07 12:30		DOJ and FTC Aim to Increase Merger Enforcement
2022-03-04 12:30		Price Transparency: Making Things Clearer or More Confusing?
2022-03-03 12:30		GAO Adds HHS to High Risk List of Agencies that Need Transformation
2022-03-02 12:30		CMS Sends Out Warning Notices for Transparency Rule Non-Compliance, But No Fines
2022-03-01 12:30		Continuous Professional Development for Drug Prescribing Associated with Reduced Health Care Costs

<< Archive Index • Subscribe >>